Hydra Biosciences Company

Hydra Biosciences develops novel drugs to treat pain, inflammation, cardiovascular and other diseases using ion channels.

Estimated Revenue: $1M to $10M
Funding Status: Late Stage Venture
Headquarters: Cambridge, Massachusetts, United States
Founded Date: 2001
Technology: Cancer
Industry: PharmTech
Employee Number: 11-50